These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10941298)

  • 1. [Recommendations of the Belgian Lipid Club for the diagnosis and treatment of hyperlipidemias: summary for the practitioner].
    Ducobu J; Scheen AJ
    Rev Med Liege; 2000 May; 55(5):360-6. PubMed ID: 10941298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on statins and other lipid-lowering drugs.
    Miller CA
    Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical practice guidelines for the management of dyslipidemia.
    Nichols N
    Can J Cardiovasc Nurs; 2004; 14(2):7-10. PubMed ID: 15230023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of hyperlipidemia-induced atherosclerosis.
    Tannock LR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of evidence-based principles of care in older persons (issue 2): management of lipid disorders.
    Zarowitz BJ; Aronow WS; Hollenack K; O'Shea T
    J Am Med Dir Assoc; 2006 Mar; 7(3):173-9. PubMed ID: 16503311
    [No Abstract]   [Full Text] [Related]  

  • 6. The New 2018 Cholesterol Guidelines.
    Khera A
    Circulation; 2019 Jun; 139(25):2805-2808. PubMed ID: 30586686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dyslipidemia and global cardiovascular risk: treatment guidelines].
    Vigna GB; Fellin R
    Ital Heart J; 2003 Dec; 4 Suppl 7():4S-12S. PubMed ID: 14983742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the inapplicability of certain therapeutic guidelines in practice: the example of reimbursement for hypolipidemic agents in Belgium].
    Scheen AJ
    Rev Med Liege; 2000 Apr; 55(4):260-4. PubMed ID: 10909311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing CVD risk - integration of clinical and laboratory criteria.
    Tognarini DP; Sullivan DR; Thomas DW; Sikaris K
    Aust Fam Physician; 2008 Jun; 37(6):422-7. PubMed ID: 18523695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugar and fat, a recipe for disaster. New guidelines for the pharmacological management of diabetic dyslipidaemia.
    Tallis GA; Beng C; Popplewell P; Phillips P
    Aust Fam Physician; 1995 Sep; 24(9):1638-9, 1642-7, 1649. PubMed ID: 7487649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
    Genest J; Frohlich J; Fodor G; McPherson R;
    CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for diagnosis and treatment of adult hyperlipidaemias. Consensus of the Belgian Lipid Club.
    Ducobu J; Daubresse JC
    Acta Clin Belg; 1994; 49(5):243-8. PubMed ID: 7992570
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association Guidelines.
    Wenger NK
    Adv Chronic Kidney Dis; 2013 Sep; 20(5):419-22. PubMed ID: 23978547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D; Krone W
    Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of European guidelines: changing the management of cholesterol levels.
    Erhardt LR; Gotto A
    Atherosclerosis; 2006 Mar; 185(1):12-20. PubMed ID: 16309687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.
    McPherson R; Frohlich J; Fodor G; Genest J; Canadian Cardiovascular Society
    Can J Cardiol; 2006 Sep; 22(11):913-27. PubMed ID: 16971976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease.
    Thompson GR
    Atheroscler Suppl; 2013 Jan; 14(1):67-70. PubMed ID: 23357143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?].
    Fretheim A; Bjørndal A; Oxman AD; Dyrdal A; Golding M; Ose L; Reikvam A; Teisberg P
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2287-8. PubMed ID: 12448270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in cardiovascular prevention?
    Brohet CR
    Acta Clin Belg; 2007; 62(5):317-22. PubMed ID: 18229465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?
    Glaser NS; Geller DH; Haqq A; Gitelman S; Malloy M;
    Pediatr Diabetes; 2011 Jun; 12(4 Pt 2):442-59. PubMed ID: 21054719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.